Targeted Therapy in Lung Cancer: The Importance of Biomarkers - LCVL 2024

Future Directions of Lung Cancer Treatment: Minimal Residual Disease - LCVL 2024Подробнее

Lung Cancer Risk Factors and Prior Treatment Options - LCVL 2024Подробнее

The Importance of Biomarkers in NSCLC - LCVL 2024Подробнее

Biomarkers in NSCLC - Targeted Therapies in Lung Cancer 2023Подробнее

Biomarker Driven Therapy for NSCLC - Targeted Therapies in Lung Cancer 2023Подробнее

Candid Conversations in Lung Cancer: Discussing Biomarker Testing and Targeted TherapiesПодробнее

The Importance of Biomarkers for Lung CancerПодробнее

Andreas Wicki presents the latest advancements in medical oncologyПодробнее

Fine-Tuning Biomarker Testing to Identify and Target RET Fusions in NSCLCПодробнее

Lung Cancer Biomarkers & Targeted Therapies - WebinarПодробнее

Biomarker Targeted Therapy For Lung CancerПодробнее

Dr. Chaft on Predictive Biomarkers in Lung CancerПодробнее

Updates on biomarkers for therapy in lung cancerПодробнее

Emerging Biomarkers in Lung CancerПодробнее

Guiding NSCLC treatment with biomarkersПодробнее

Lung Cancer and Biomarker Testing: Two Families’ StoriesПодробнее

Dr. Rimm on Biomarker Testing in Lung CancerПодробнее

Clinical Trials and Lung Cancer BiomarkersПодробнее

Treatment Strategies for KRAS+ NSCLC - LCVL 2024Подробнее